FDA OKs First Treatment for Friedreich's Ataxia FDA OKs First Treatment for Friedreich's Ataxia
Omaveloxolone has been approved for adults and adolescents aged 16 and older who have the ultra-rare neurodegenerative disorder Friedreich ' s ataxia.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 1, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Stocks in focus: Reata Pharmaceuticals stock soars after FDA-drug approval; Novavax falls after vaccine maker issues ‘substantial doubts’ over future operations
Here are U.S. stocks in focus ahead of Wednesday’s trading session: Reata Pharmaceuticals’ RETA stock shot up more than 177% on Wednesday morning after the Food and Drug administration approved a drug treatment for a disease called Friedreich’s ataxia, a rare inherited disease that causes damage…#reatapharmaceuticals #foodanddrug (Source: Reuters: Health)
Source: Reuters: Health - March 1, 2023 Category: Consumer Health News Source Type: news
FDA approves first treatment for Friedreich ’s ataxia
FDA has approved Skyclarys (omaveloxolone) as the first treatment for Friedreich ’s ataxia, a rare, inherited, degenerative disease that damages the nervous system, characterized by impaired coordination and walking. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 28, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Approves Skyclarys (omaveloxolone) for the Treatment of Friedreich ’s Ataxia
PLANO, Texas--(BUSINESS WIRE) February 28, 2023 -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the“Company,”“our,”“us,” or“we”), a biopharmaceutical company focused on... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 28, 2023 Category: Drugs & Pharmacology Source Type: news
Morning Walk( ®)-assisted gait training improves walking ability and balance in patients with ataxia: a randomized controlled trial - Jung C, Kim DY, Kwon S, Chun MH, Kim JY, Kim SH.
This study aimed to investigate walking ability and balance improvement of patients with ataxia caused by brain lesions after end-effector type robot (Morning Walk( ®))-assisted gait training. This study randomly assigned 19 patients to one of two groups: ... (Source: SafetyLit)
Source: SafetyLit - February 8, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Mechanism behind rare ataxia disease found by NIEHS scientists
<img width="100" src="https://factor.niehs.nih.gov/sites/niehs-factor/files/styles/large/public/2018/8/feature/feature-2-mechanism/thumb851204.jpg?itok=-vsN18Yv" /><br /><p>NIEHS researchers reported how inactivation of a protein causes the rare disorder known as ataxia with oculomotor apraxia 1.</p>
(read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - February 3, 2023 Category: Environmental Health Source Type: news
Boy, 16, suffered ataxia and muscle wasting for years due to vitamin E deficiency
One patient's symptoms, which included generalised weakness throughout his body, started when he was just 10 years old. (Source: Daily Express - Health)
Source: Daily Express - Health - January 17, 2023 Category: Consumer Health News Source Type: news
Ataxia could be an 'early' sign of a stroke - can appear a week before the attack
Stroke strikes every five minutes, claiming 35,000 lives each year in the UK. (Source: Daily Express - Health)
Source: Daily Express - Health - January 13, 2023 Category: Consumer Health News Source Type: news
Experiencing 'ataxia' while walking can signal 'irreversible' B12 deficiency, warns NHS
People with vitamin B12 deficiency have also reported experiencing memory loss and visual problems. (Source: Daily Express - Health)
Source: Daily Express - Health - November 20, 2022 Category: Consumer Health News Source Type: news
Vitamin B12 deficiency symptoms: Ataxia may signal your nervous system is compromised
Ignoring the warning sign for too long could lead to permanent nerve damage, even if the cause is treated. (Source: Daily Express - Health)
Source: Daily Express - Health - October 10, 2022 Category: Consumer Health News Source Type: news
Mutations in protein kinase C γ promote spinocerebellar ataxia type 14 by impairing kinase autoinhibition | Science Signaling
Biochemical characterization of mutations that cause a neurodegenerative disease provides pathological insight. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - September 27, 2022 Category: Science Source Type: news
Jumping Genes Can Cause Movement Disorder: Study
Mice with overactive LINE-1 retrotransposons in their brains exhibit movement difficulties, suggesting the genetic elements may play a role in ataxia in humans. (Source: The Scientist)
Source: The Scientist - September 13, 2022 Category: Science Tags: News & Opinion Source Type: news
Reata Pharmaceuticals Announces Three Month Extension of the Review Period for New Drug Application for Omaveloxolone for the Treatment of Friedreich ’s Ataxia
Reata Submitted New Data and Analyses to Address FDA Questions During Mid-Cycle Meeting
FDA Extended PDUFA Date to Provide Time for Full Review of New Submissions
PDUFA Date Extended to February 28, 2023
PLANO, Texas--(BUSINESS WIRE) August... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 9, 2022 Category: Drugs & Pharmacology Source Type: news
Picture of Ataxia Telangiectasia (Legs)
Title: Picture of Ataxia Telangiectasia (Legs)Category: ImagesCreated: 1/6/2010 12:53:00 PMLast Editorial Review: 7/12/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - July 12, 2022 Category: Dermatology Source Type: news
Picture of Ataxia Telangiectasia (Ear)
Title: Picture of Ataxia Telangiectasia (Ear)Category: ImagesCreated: 1/6/2010 11:22:00 AMLast Editorial Review: 7/12/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - July 12, 2022 Category: Dermatology Source Type: news
